vazyme is Nanjing Novozymes Biotechnology Co. Novizen has always been adhering to innovation, committed to breakthroughs, insisting on research and development from the source of technology, relying on independent core technology, building an independent and controllable key **** technology platform, which allows for rapid, efficient and large-scale product development, with more than 200 genetically engineered recombinant enzymes and more than 1,000 key raw materials such as high-performance antigens and monoclonal antibodies, and with more than 500 end-products
Products
Novizen has always adhered to the R&D-centered business philosophy since its inception, relying on its own core technologies, constantly updating and upgrading its technologies, and exploring new business areas. Through years of diligent pursuit, Novozymes has made technical achievements in biomedical fields. It has successfully launched several series of biological reagents including high-throughput sequencing library construction series, PCR series, qPCR series, molecular cloning series, reverse transcription series, Bio-assay, etc. and 8 series of POCT diagnostic reagents including cardiovascular, cerebral vascular, inflammation and infection, eugenics and gastric function, etc., and has formed an organization that covers scientific research colleges and universities, high-throughput sequencing service enterprises, molecular diagnostic reagent manufacturers, pharmaceutical enterprises, CRO enterprises, and other enterprises. We have also formed a customer portfolio covering research institutes, high-throughput sequencing service companies, molecular diagnostic reagent manufacturers, pharmaceutical companies, CRO companies, hospitals and other medical institutions.